Diacylglycerol acyltransferase inhibitors
Provided herein are compounds of the formula (I): were RI is phenyl, R2 is hydrogen, halogen or lower alkyl, X is carbon on nitrogen, and R3 is isoquinoline, -amino, or a -4- to 6-membered heterocycloalkyl ring and pharmaceutically acceptable salts thereof, which are active as DGAT inhibitors and therefore find uses in treatment of diseases associated with abnormal metabolism of trigliceride. such as, for example, obesity, type II diabetes mellitus and metabolic syndrome.
1. A compound of formula (I):
wherein
X is nitrogen;
R1 is -phenyl, unsubstituted or mono- or di-substituted independently with halogen, lower alkyl, lower alkanoic acid, lower alkanoyl, lower alkyl ester of lower alkanoic acid, haloloweralkyl, unsubstituted phenyl, halophenyl, alkoxyphenyl or phenyl substituted with haloloweralkyl,
R2 is H, halogen or loweralkyl; and
R3 is a piperazine ring, said ring being mono- or di-substituted, independently, with halogen, hydroxy, lower alkoxy, phenyl, phenyl substituted with haloloweralkyl, halophenyl, benzoic acid, lower alkyl ester of benzoic acid, lower alkyl oxadiazole, phenyl-pyridine, lower alkanoyl, lower alkanoic acid, lower alkyl ester of lower alkanoic acid, carbamic acid tert-butyl ester, N-alkyl carbamic acid tert-butyl ester, —CH 2 -halophenyl, —SO 2 -phenyl, acetylamino, methyltriazole, —C(O)NSO 2 —C(CH 3 ) 3 , benzoic acid benzyl ester, pyridine substituted with C(O)OH, phenyl substituted with lower alkanoic acid, phenyl substituted with lower alkyl ester of lower alkanoic acid, halobenzoic acid, lower alkyl benzoic acid, lower alkyl ester of halobenzoic acid, lower alkyl ester of lower alkyl benzoic acid, lower alkoxy benzoic acid, lower alkyl ester of lower alkoxy benzoic acid, lower alkoxy phenyl, 2,2-dimethyl-4-oxobutyric acid, 2-oxo-ethyl cyclopentanecarboxylic acid, 3,3-dimethyl-5-oxo-pentanoic acid, carbonyl-cyclohexanecarboxylic acid methyl ester, carbonyl-cyclopropane, (2,4-dioxo-thiazolidin-5-yl)-acetyl, carbonyl-ethyl-(3-hydroxy-isoxazol-5-yl), carbonyl-cyclohexanecarboxylic acid, carbonyl-cyclopentanecarboxylic acid, ethanesulfonylaminocarbonyl-cyclohexanecarbonyl, carbonyl-amino-propionic acid ethyl ester, carboxylic acid tert-butylamide, carboxylic acid ethylamide, carbonyl-amino-acetic acid ethyl ester, or —C(O)CH 2 C(CH 3 ) 3 ;
or a pharmaceutically acceptable salt thereof.
2. The compound of claim 1 , wherein R1 is 3 methylester phenyl, 3-tert-butyl phenyl, 3-iodo-4-methyl-phenyl, 4-chloro-3-iodo-phenyl, 3 chloro-4-iodo-phenyl, 3-fluoro-5-iodophenyl, or 3-methoxyphenyl.
3. The compound of claim 1 , wherein R2 is hydrogen.
4. The compound of claim 1 , wherein R3 is 4-(piperazin-1-yl)-benzoic acid, 6-piperazin-1-yl-nicotinic acid, 3-(4-piperazin-1-yl-phenyl)-propionic acid, 3 chloro-4-piperazin-1-yl-benzoic acid, 3-fluoro-4-piperazin-1-yl-benzoic acid, or 3-methyl-4-piperazin-1-yl-benzoic acid.
5. A compound, wherein said compound is
4-{4-[5-(3-tert-butyl-phenylcarbamoyl)-pyridin-2-yl]-piperazin-1-yl}-benzoic acid;
4-{4-[5-(3-iodo-4-methyl-phenylcarbamoyl)-pyridin-2-yl]-piperazin-1-yl}-benzoic acid;
4{4-[4-(3-tert-butyl-phenylcarbamoyl)-phenyl]-piperazin-1-yl}-benzoic acid;
4-{4-[5-(3-chloro-4-iodo-phenylcarbamoyl)-pyridin-2-yl]-piperazin-1-yl}-benzoic acid;
4-{4-[4-(3-tert-butyl-phenylcarbamoyl)-phenyl]-piperidin-1-yl}-2-methyl-benzoic acid;
4-{4-[4-(3-tert-butyl-phenylcarbamoyl)-phenyl]-piperidin-1-yl}-2-fluoro-benzoic acid;
4-{4-[4-(3-tert-butyl-phenylcarbamoyl)-phenyl]-piperidin-1-yl}-2-chloro-benzoic acid;
4-[4-[4-(3-tert-butyl-phenylcarbamoyl)-phenyl]-piperidin-1-yl]-3-methyl-benzoic acid;
4-[4-[5-(4-chloro-3-iodo-phenylcarbamoyl)-pyridin-2-yl]-piperazin-1-yl]-benzoic acid;
3-methyl-4-{4-[5-(1-ethyl-1H-indol-6-ylcarbamoyl)-pyridin-2-yl]-piperazin-1-yl}-benzoic acid;
4-{4-[4-(3-tert-butyl-phenylcarbamoyl)-2-chloro-phenyl]-piperazin-1-yl}-benzoic acid;
3-chloro-4-[4-[5-(1-ethyl-1H-indol-6-ylcarbamoyl)-pyridin-2-yl]-piperazin-1-yl]-benzoic acid;
(4-{4-[5-(3-tert-butyl-phenylcarbamoyl)-pyridin-2-yl]-piperazin-1-yl}-phenyl)-propionic acid;
2-methyl-4-{4-[5-(1-ethyl-1H-indol-6-ylcarbamoyl)-pyridin-2-yl]-piperazin-1-yl}-benzoic acid;
4-{4-[4-(5-ethyl-4-phenyl-thiazol-2-ylcarbamoyl)-phenyl]-piperazin-1-yl}-benzoic acid;
4-(3-methyl-[1,2,4]oxadiazol-5-yl)-3,4,5,6-tetrahydro-2H[1,2′]bipyridinyl-5′-carboxylic acid (5-methyl-4-phenyl-thiazol-2-yl)-amide;
4-[4-[4-(3-tert-butyl-phenylcarbamoyl)-phenyl]-piperidin-1-yl]-benzoic acid;
4-[4-[5-(1-ethyl-1H-indol-6-ylcarbamoyl)-pyridin-2-yl]-piperazin-1-yl]-benzoic acid;
4-{4-[5-(4-tert-butyl-phenylcarbamoyl)-pyridin-2-yl]-piperazin-1-yl}-benzoic acid; or
4-hydroxy-4-(3-trifluoromethyl-phenyl)-3,4,5,6-tetrahydro-2H[1,2′]bipyridinyl-5′-carboxylic acid (5-methyl-4-phenyl-thiazol-2-yl)-amide, or pharmaceutically acceptable salts thereof.
6. The compound of claim 1 wherein R3 is piperazine substituted with benzoic acid or an ester of benzoic acid.
7. The compound of claim 6 wherein said compound is 4-{4-[5-(4-tert-butyl-phenylcarbamoyl)-pyridin-2-yl]-piperazin-1-yl}-benzoic acid or pharmaceutically acceptable salts thereof.
8. The compound of claim 6 wherein said compound is 4-{4-[5-(3-iodo-4-methyl-phenylcarbamoyl)-pyridin-2-yl]-piperazin-1-yl}-benzoic acid or pharmaceutically acceptable salts thereof.
9. The compound of claim 6 wherein said compound is 4-{4-[5-(3-chloro-4-iodo-phenylcarbamoyl)-pyridin-2-yl]-piperazin-1-yl}-benzoic acid or pharmaceutically acceptable salts thereof.
10. The compound of claim 6 wherein said compound is 4-{4-[5-(4-chloro-3-iodo-phenylcarbamoyl)-pyridin-2-yl]-piperazin-1-yl}-benzoic acid or pharmaceutically acceptable salts thereof.
11. The compound of claim 1 wherein R3 is piperazine substituted with phenyl, phenyl-lower-alkanoic acid or phenyl lower alkanoic acid lower alkyl ester.
12. The compound of claim 11 wherein said compound is (4-{4-[5-(3-tert butyl-phenylcarbamoyl)-pyridin-2-yl]-piperazin-1-yl}-phenyl)-propionic acid or pharmaceutically acceptable salts thereof.
13. A compound of formula (I):
Wherein
X is nitrogen;
R1 is -phenyl, unsubstituted or mono- or di-substituted independently with lower alkyl, lower alkanoic acid, lower alkanoyl, lower alkyl ester of lower alkanoic acid, haloloweralkyl, unsubstituted phenyl, halophenyl, alkoxyphenyl or phenyl substituted with haloloweralkyl,
R2 is H, halogen or loweralkyl; and
R3 is a piperazine ring, said ring being unsubstituted or mono- or di-substituted, independently, with lower alkyl, halogen, hydroxy, lower alkoxy, phenyl, phenyl substituted with lower alkyl, phenyl substituted with haloloweralkyl, halophenyl, benzoic acid, lower alkyl ester of benzoic acid, lower alkyl oxadiazole, phenyl-pyridine, lower alkanoyl, lower alkanoic acid, lower alkyl ester of lower alkanoic acid, carbamic acid tert-butyl ester, N-alkyl carbamic acid tert-butyl ester, —CH 2 -halophenyl, —SO 2 -phenyl, acetylamino, methyltriazole, —C(O)NSO 2 —C(CH 3 ) 3 , benzoic acid benzyl ester, pyridine substituted with C(O)OH, phenyl substituted with lower alkanoic acid, phenyl substituted with lower alkyl ester of lower alkanoic acid, halobenzoic acid, lower alkyl benzoic acid, lower alkyl ester of halobenzoic acid, lower alkyl ester of lower alkyl benzoic acid, lower alkoxy benzoic acid, lower alkyl ester of lower alkoxy benzoic acid, lower alkoxy phenyl, 2,2-dimethyl-4-oxobutyric acid, 2-oxo-ethyl cyclopentanecarboxylic acid, 3,3-dimethyl-5-oxo-pentanoic acid, carbonyl-cyclohexanecarboxylic acid methyl ester, carbonyl-cyclopropane, (2,4-dioxo-thiazolidin-5-yl)-acetyl, carbonyl-ethyl-(3-hydroxy-isoxazol-5-yl), carbonyl-cyclohexanecarboxylic acid, carbonyl-cyclopentanecarboxylic acid, ethanesulfonylaminocarbonyl-cyclohexanecarbonyl, carbonyl-amino-propionic acid ethyl ester, carboxylic acid tert-butylamide, carboxylic acid ethylamide, carbonyl-amino-acetic acid ethyl ester, or —C(O)CH 2 C(CH 3 ) 3 ;
or a pharmaceutically acceptable salt thereof.